亚盛医药-B授出130.45万份受限制股份单位及73.66万份购股权

Core Viewpoint - As of the announcement date, the company has granted a total of 1,304,500 restricted stock units (RSUs) to 146 selected individuals under the 2022 Restricted Stock Unit Plan, which corresponds to 1,304,500 shares [1] Summary by Categories Restricted Stock Units - The company has awarded 1,304,500 RSUs to 146 selected individuals under the 2022 plan, with further grants expected in 2022 [1] Stock Options - The company has granted a total of 736,600 stock options to 34 recipients under the post-initial public offering stock option plan, which allows for the subscription of an equivalent number of ordinary shares, pending acceptance by the option recipients [1]